These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 10422338
1. [Post-vaccination immunity after allogenic and autologous bone marrow transplantation]. Skovránková J. Cas Lek Cesk; 1999 May 10; 138(10):298-300. PubMed ID: 10422338 [Abstract] [Full Text] [Related]
2. Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines. Nordøy T, Husebekk A, Aaberge IS, Jenum PA, Samdal HH, Flugsrud LB, Kristoffersen AC, Holte H, Kvaløy S, Kolstad A. Bone Marrow Transplant; 2001 Oct 10; 28(7):681-7. PubMed ID: 11704791 [Abstract] [Full Text] [Related]
3. [Kinetics of vaccination antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogenic and autologous bone marrow transplantation and booster vaccination. 2: Kinetics of vaccination antibodies against diphtheria toxoid after allogenic and autologous bone marrow transplantation]. Prager J, Thilo W, Hermann J, Fuchs D, Zintl F. Kinderarztl Prax; 1992 Oct 10; 60(7):195-8. PubMed ID: 1434337 [Abstract] [Full Text] [Related]
4. [The kinetics of vaccine antibodies against tetanus toxoid, diphtheria toxoid, measles virus, poliomyelitis virus and pneumococcus after allogeneic and autologous bone marrow transplantation and revaccination. 3: The kinetics of vaccine antibodies against tetanus toxoid and diphtheria toxoid after allogeneic and autologous bone marrow transplantation and combined revaccination against diphtheria and tetanus]. Prager J, Baumert A, Thilo W, Hermann J, Fuchs D, Sauerbrey A, Zintl F. Kinderarztl Prax; 1992 Nov 10; 60(8):230-8. PubMed ID: 1469826 [Abstract] [Full Text] [Related]
5. A randomized study on donor immunization with tetanus-diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation. Parkkali T, Käyhty H, Hovi T, Olander RM, Roivainen M, Volin L, Ruutu T, Lahdenkari M, Ruutu P. Bone Marrow Transplant; 2007 Feb 10; 39(3):179-88. PubMed ID: 17211432 [Abstract] [Full Text] [Related]
9. Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children. Schwinger W, Weber-Mzell D, Zois B, Rojacher T, Benesch M, Lackner H, Dornbusch HJ, Sovinz P, Moser A, Lanzer G, Schauenstein K, Ofner P, Handgretinger R, Urban C. Br J Haematol; 2006 Oct 10; 135(1):76-84. PubMed ID: 16925797 [Abstract] [Full Text] [Related]
10. Active vaccination after allogeneic bone marrow cell transplantation: a new option in the immunotherapy of cancer? Zöller M, Matzku S. Arch Immunol Ther Exp (Warsz); 2002 Oct 10; 50(3):197-224. PubMed ID: 12098935 [Abstract] [Full Text] [Related]
12. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. Patel SR, Ortín M, Cohen BJ, Borrow R, Irving D, Sheldon J, Heath PT. Clin Infect Dis; 2007 Mar 01; 44(5):625-34. PubMed ID: 17278051 [Abstract] [Full Text] [Related]
13. The potential role of bone marrow transplantation in augmenting donor-derived immunity to hepatitis B after rat liver transplantation. Li J, Dahmen U, Dirsch OR, Gu Y, Polywka S, Fiedler M, Doebel L, Roggendorf M, Broelsch CE. Liver Transpl; 2002 Apr 01; 8(4):397-404. PubMed ID: 11965586 [Abstract] [Full Text] [Related]
14. Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation. Ljungman P, Cordonnier C, de Bock R, Einsele H, Engelhard D, Grundy J, Link H, Locasciulli A, Prentice G, Reusser P. Bone Marrow Transplant; 1995 Mar 01; 15(3):455-60. PubMed ID: 7599572 [Abstract] [Full Text] [Related]
15. Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation. Teshima T, Mach N, Hill GR, Pan L, Gillessen S, Dranoff G, Ferrara JL. Cancer Res; 2001 Jan 01; 61(1):162-71. PubMed ID: 11196155 [Abstract] [Full Text] [Related]
16. Distinct phases in recovery of reconstituted innate cellular-mediated immunity after murine syngeneic bone marrow transplantation. Auletta JJ, Devecchio JL, Ferrara JL, Heinzel FP. Biol Blood Marrow Transplant; 2004 Dec 01; 10(12):834-47. PubMed ID: 15570252 [Abstract] [Full Text] [Related]
17. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice. Du B, Li DP, Xu KL, Pan XY. Chin Med J (Engl); 2005 Mar 20; 118(6):474-9. PubMed ID: 15788128 [Abstract] [Full Text] [Related]
18. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines. Parkkali T, Käyhty H, Anttila M, Ruutu T, Wuorimaa T, Soininen A, Volin L, Ruutu P. Bone Marrow Transplant; 1999 Sep 20; 24(6):671-8. PubMed ID: 10490735 [Abstract] [Full Text] [Related]
19. Opsonophagocytic activity against Streptococcus pneumoniae type 19F in allogeneic BMT recipients before and after vaccination with pneumococcal polysaccharide vaccine. Parkkali T, Väkeväinen M, Käyhty H, Ruutu T, Ruutu P. Bone Marrow Transplant; 2001 Jan 20; 27(2):207-11. PubMed ID: 11281392 [Abstract] [Full Text] [Related]
20. Vaccination responses and lymphocyte subsets after autologous stem cell transplantation. van der Velden AM, Claessen AM, van Velzen-Blad H, de Groot MR, Kramer MH, Biesma DH, Rijkers GT. Vaccine; 2007 Dec 12; 25(51):8512-7. PubMed ID: 17996989 [Abstract] [Full Text] [Related] Page: [Next] [New Search]